Organon & Co. (OGN)
6.56
-0.15
(-2.24%)
USD |
NYSE |
Mar 06, 16:00
6.60
+0.04
(+0.61%)
After-Hours: 20:00
Organon Cash from Investing (Quarterly) : -65.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -11.20B |
| Amphastar Pharmaceuticals, Inc. | -60.57M |
| Plus Therapeutics, Inc. | 1.297M |
| Geron Corp. | 21.14M |
| Vertex Pharmaceuticals, Inc. | -288.10M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 141.00M |
| Cash from Financing (Quarterly) | -187.00M |
| Free Cash Flow | 508.00M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 228.00M |
| Free Cash Flow to Firm (Quarterly) | 370.37M |
| Free Cash Flow Yield | 29.73% |